Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
"This is particularly concerning given that people with obesity-related comorbidities may reap the greatest benefit from treatment," said Professor Thomsen
Notably, this was true in three different BMI classes, according to the study
Neurology 75(18):16391644
This was assessed using a PHERAstar (BMG LabTech) at 10 sec intervals (25 C)
However Eli Lilly is seeking to get the drug authorised in the US for obesity, which would put it further in competition with Danish firm Novo Nordisk's semaglutide drug, known as Ozempic for diabetes treatment or Wegovy for weight loss
US$ 21.67
US$ 24.25
US$ 23.41
US$ 28.56
US$ 25.08
